Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Pharmacol Ther ; 110(4): 926-940, 2021 10.
Artigo em Inglês | MEDLINE | ID: mdl-33763871

RESUMO

Malaria is an infectious disease which disproportionately effects children and pregnant women. These vulnerable populations are often excluded from clinical trials resulting in one-size-fits-all treatment regimens based on those established for a nonpregnant adult population. Pharmacokinetic/pharmacodynamic (PK/PD) models can be used to optimize dose selection as they define the drug exposure-response relationship. Additionally, these models are able to identify patient characteristics that cause alterations in the expected PK/PD profiles and through simulations can recommend changes to dosing which compensate for the differences. In this review, we examine how PK/PD models have been applied to optimize antimalarial dosing recommendations for young children, including those who are malnourished, pregnant women, and individuals receiving concomitant therapies such as those for HIV treatment. The malaria field has had great success in utilizing PK/PD models as a foundation to update treatment guidelines and propose the next generation of dosing regimens to investigate in clinical trials. We propose how the malaria field can continue to use modeling to improve therapies by further integrating PK data into clinical studies and including data on drug resistance and host immunity in PK/PD models. Finally, we suggest that other disease areas can achieve similar success in applying pharmacometrics to improve outcomes by implementing three key principals.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Antimaláricos/uso terapêutico , Saúde Global , Infecções por HIV/tratamento farmacológico , Malária/tratamento farmacológico , Desnutrição/metabolismo , Complicações Parasitárias na Gravidez/tratamento farmacológico , Populações Vulneráveis , Amodiaquina/farmacologia , Amodiaquina/uso terapêutico , Antimaláricos/farmacologia , Combinação Arteméter e Lumefantrina/farmacologia , Combinação Arteméter e Lumefantrina/uso terapêutico , Artemisininas/farmacologia , Artemisininas/uso terapêutico , Artesunato/farmacologia , Artesunato/uso terapêutico , Pré-Escolar , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Interações Medicamentosas , Quimioterapia Combinada , Feminino , Infecções por HIV/complicações , Humanos , Mefloquina/farmacologia , Mefloquina/uso terapêutico , Modelos Biológicos , Gravidez , Pirimetamina/farmacologia , Pirimetamina/uso terapêutico , Quinolinas/farmacologia , Quinolinas/uso terapêutico , Sulfadoxina/farmacologia , Sulfadoxina/uso terapêutico
2.
Bull Cancer ; 106(12): 1160-1176, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31757405

RESUMO

Radiation induced optic neuropathy (RION) is a rare but disastrous complication of radiation therapy in treatment of periorbital tumors. The objective of this study is to investigate the incidence of RION in series of patients treated from peri orbital tumors by recent photon and proton irradiation modalities. We searched the Pub Med database for studies in periorbital tumors including base of skull, sinonasal, pituitary, nasopharyngeal tumors and craniopharyngioma treated with Intensity modulated radiotherapy (IMRT) and with proton beam therapy (PBT) between 1992 and 2017 excluding metastatic tumors, lymphomas, pediatric series, those treated mainly with chemotherapy, target therapy and those written in languages other than English and French. The result retrieved 421 articles that were revised by the panel. Fourteen articles with IMRT and 27 with PBT reported usable data for the review from which 31studies that had pointed to the doses to the optic nerve (ON) and/or optic chiasm (OC) and incidence of RION have been analyzed. We have found that the incidence of RION had been reported fairly in both modalities and many other factors related to the patient, tumor, and irradiation process interplay in its development. We have concluded that proper treatment planning, good selection of treatment modality, adherence to dose constraints applied to critical structures all along with regular oncological and ophthalmological follow up, control of co-morbidities and early intervention, could help reducing its magnitude.


Assuntos
Terapia com Prótons/efeitos adversos , Lesões por Radiação/complicações , Radioterapia de Intensidade Modulada/efeitos adversos , Neuropatia Óptica Tóxica/etiologia , Adenoma/radioterapia , Craniofaringioma/radioterapia , Humanos , Incidência , Neoplasias Nasofaríngeas/radioterapia , Neoplasias Nasais/radioterapia , Neoplasias dos Seios Paranasais/radioterapia , Neoplasias Hipofisárias/radioterapia , Neoplasias da Base do Crânio/radioterapia , Neuropatia Óptica Tóxica/epidemiologia
3.
Open Access Maced J Med Sci ; 7(15): 2520-2527, 2019 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-31666858

RESUMO

BACKGROUND: The success of implants is associated first with their osseointegration, and later on with their survival rate. In recent years, many efforts have been exerted to develop implant design, geometry, materials and techniques to enhance the osseointegration process and also to increase the success rate of implant procedures. New techniques, like leukocyte and platelet-rich fibrin (L-PRF) and low-level laser treatment (LLLT), have been developed to enhance the osseointegration around dental implants. AIM: This study aims at accelerating bone osseointegration process around dental implant using new techniques to increase the success rate, to allow immediate or early loading of a dental implant, and to make a comparison between the various new techniques in dental implant procedures to figure out which technique will achieve the best results. METHODS: The study was conducted on a random sample of 40 male patients. Dental implants were placed in the posterior areas of the lower jaw. Patients were divided randomly into 4 groups; control group, LLLT group, L-PRF group and L-PRF plus LLLT group. They were assessed using cone-beam computed tomography (CBCT). RESULTS: The results showed significant differences between all groups over different measured times. All the groups showed improvement in comparison with Normal group, where L-PRF group showed the best result followed by (L-PRF+LLLT) group, while the LLLT group showed the least improvement in comparison with bothL-PRF group and (L-PRF+LLLT) group. CONCLUSION: The study demonstrates that L-PRF gives a better performance in the osseointegration around dental implants than LLLT.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...